*Dr. Qu received her Bachelor's and Master's degrees from Tsinghua University and her Ph.D. from the Johns Hopkins University; Dr. Qu completed her Postdoctoral fellowship in Washington University Medical School. *Dr. Qu was a Principal Investigator (PI) leading a drug discovery program in Southern Research Institute (SRI), focused on cancer research and anti-cancer drug discovery and development. *Over 30 years, Dr. Qu has accumulated extensive experience in the field of cancer research and anti-cancer drug development. Currently, Dr. Qu is leading Nanolattix Group focusing on Antibody Drug Conjugates (ADC) and Radionuclide Drug Conjugates (RDC) drug development.